Fan et al. established that silencing of EZH2 secretory levels was linked to a TMZ-resistant phenotype in GBM cells during gene secretory analysis of both the TMZ-sensitive and TMZ-resistant GBM cell lines [9]. The gene discussed is EZH2; the disease is glioblastoma.